Published in Behav Biol on August 01, 1978
Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA (2001) 8.40
Eucaryotic RNA polymerase conditional mutant that rapidly ceases mRNA synthesis. Mol Cell Biol (1987) 5.93
Breast tumor cell lines from pleural effusions. J Natl Cancer Inst (1974) 5.39
Holins: the protein clocks of bacteriophage infections. Annu Rev Microbiol (2000) 5.30
Crystal structures of two Sm protein complexes and their implications for the assembly of the spliceosomal snRNPs. Cell (1999) 4.57
Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1989) 4.45
Use of regulated cell lysis in a lethal genetic selection in Escherichia coli: identification of the autoinducer-binding region of the LuxR protein from Vibrio fischeri ATCC 7744. J Bacteriol (1990) 2.64
Pressures within air-filled tracheal cuffs at altitude--an in vivo study. Anaesthesia (2004) 2.61
Formation of cyclic 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res (1984) 2.41
Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol (1999) 2.24
Dominance in lambda S mutations and evidence for translational control. J Mol Biol (1988) 2.24
Occupational exposure to carcinogens in the European Union. Occup Environ Med (2000) 2.18
Lethal action of bacteriophage lambda S gene. J Virol (1982) 2.10
A protein antibiotic in the phage Qbeta virion: diversity in lysis targets. Science (2001) 2.07
Holins kill without warning. Proc Natl Acad Sci U S A (2001) 2.05
Introduction of 6-mercaptopurine in Crohn's disease patients during the perioperative period: a preliminary evaluation of recurrence of disease. J Pediatr Gastroenterol Nutr (1997) 2.04
The prevalence of common skin conditions in Australian school students: 1. Common, plane and plantar viral warts. Br J Dermatol (1998) 2.01
Cloning and characterization of a hemolysin gene from Actinobacillus (Haemophilus) pleuropneumoniae. DNA (1989) 1.97
Cell lysis by induction of cloned lambda lysis genes. Mol Gen Genet (1981) 1.88
Dual translational initiation sites control function of the lambda S gene. EMBO J (1989) 1.87
Transposition mutagenesis of bacteriophage lambda: a new gene affecting cell lysis. J Mol Biol (1979) 1.87
Biochemical and genetic evidence for three transmembrane domains in the class I holin, lambda S. J Biol Chem (2000) 1.86
S gene expression and the timing of lysis by bacteriophage lambda. J Bacteriol (1995) 1.84
Hemoglobin biosynthesis in murine virus-induced leukemic cells in vitro: structure and amounts of globin chains produced. Blood (1972) 1.81
The lethal lambda S gene encodes its own inhibitor. EMBO J (1990) 1.75
Lytic action of cloned phi X174 gene E. J Virol (1982) 1.72
Classification of fungal chitin synthases. Proc Natl Acad Sci U S A (1992) 1.70
Polypeptide-chain-elongation rate in Escherichia coli B/r as a function of growth rate. Biochem J (1976) 1.67
Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs. Pharmacol Biochem Behav (1997) 1.64
Role of ribosomal protein S12 in peptide chain elongation: analysis of pleiotropic, streptomycin-resistant mutants of Escherichia coli. J Bacteriol (1977) 1.63
The lambda holin accumulates beyond the lethal triggering concentration under hyperexpression conditions. Gene Expr (1998) 1.61
Genetic and biochemical analysis of dimer and oligomer interactions of the lambda S holin. J Bacteriol (2000) 1.59
Purification and biochemical characterization of the lambda holin. J Bacteriol (1998) 1.59
Frequent ED users: patterns of use over time. Am J Emerg Med (1998) 1.58
Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol (2007) 1.57
Identification and characterization of the Pasteurella haemolytica leukotoxin. Infect Immun (1987) 1.55
Factors associated with depression in students at The University of the West Indies, Mona, Jamaica. West Indian Med J (2009) 1.55
Mutational analysis of bacteriophage lambda lysis gene S. J Bacteriol (1986) 1.55
Two beginnings for a single purpose: the dual-start holins in the regulation of phage lysis. Mol Microbiol (1996) 1.53
Autonomous patients and medical professionalism. Med J Aust (1994) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Isolation of structural genes for yeast RNA polymerases by immunological screening. Proc Natl Acad Sci U S A (1986) 1.49
Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology (2003) 1.47
Subcellular localization of lethal lysis proteins of bacteriophages lambda and phiX174. J Virol (1985) 1.44
Increased plasma-free-fatty-acid concentrations and their significance in patients with acute myocardial infarction. Lancet (1969) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Dimerization between the holin and holin inhibitor of phage lambda. J Bacteriol (2000) 1.41
slyD, a host gene required for phi X174 lysis, is related to the FK506-binding protein family of peptidyl-prolyl cis-trans-isomerases. J Biol Chem (1994) 1.39
Synthesis time of beta-galactosidase in Escherichia coli B/r as a function of growth rate. Biochem J (1975) 1.37
Dual start motif in two lambdoid S genes unrelated to lambda S. J Bacteriol (1991) 1.36
Oligohistidine tag mutagenesis of the lambda holin gene. J Bacteriol (1998) 1.36
Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). Mol Pharmacol (2001) 1.35
Genetic analysis of the T4 holin: timing and topology. Gene (2001) 1.34
Genetic evidence that the bacteriophage phi X174 lysis protein inhibits cell wall synthesis. Proc Natl Acad Sci U S A (2000) 1.32
S gene product: identification and membrane localization of a lysis control protein. J Bacteriol (1983) 1.30
Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J Biol Chem (1996) 1.29
The Actinobacillus pleuropneumoniae hemolysin determinant: unlinked appCA and appBD loci flanked by pseudogenes. J Bacteriol (1991) 1.28
Functional analysis of the phage T4 holin in a lambda context. Mol Genet Genomics (2001) 1.26
Schedule-induced drinking following omission of reinforcement in the rhesus monkey. Physiol Behav (1974) 1.26
Deletion and fusion analysis of the phage phi X174 lysis gene E. Gene (1985) 1.25
Mutational analysis of slyD, an Escherichia coli gene encoding a protein of the FKBP immunophilin family. Mol Microbiol (1997) 1.25
Interaction of a transcriptional repressor with the RNA polymerase II holoenzyme plays a crucial role in repression. Proc Natl Acad Sci U S A (2001) 1.24
Characterization of the dual start motif of a class II holin gene. Mol Microbiol (1999) 1.24
Amonabactin, a novel tryptophan- or phenylalanine-containing phenolate siderophore in Aeromonas hydrophila. J Bacteriol (1989) 1.24
Resistance of citrus fruit to mass transport of water vapor and other gases. Plant Physiol (1985) 1.24
Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas. Surgery (1978) 1.23
A dominant mutation in the bacteriophage lambda S gene causes premature lysis and an absolute defective plating phenotype. Mol Microbiol (1994) 1.23
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
Epidemic Venezuelan equine encephalitis in North America in 1971: vector studies. Am J Epidemiol (1975) 1.20
Complementation and characterization of the nested Rz and Rz1 reading frames in the genome of bacteriophage lambda. Mol Gen Genet (1999) 1.20
MR-trackable intramyocardial injection catheter. Magn Reson Med (2004) 1.19
A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion. Br J Cancer (1995) 1.19
Sources of control over schedule-induced drinking produced by second-order schedules of reinforcement. Physiol Behav (1977) 1.17
Adriamycin: amelioration of toxicity by alpha-tocopherol. Cancer Treat Rep (1976) 1.16
An ancient player unmasked: T4 rI encodes a t-specific antiholin. Mol Microbiol (2001) 1.16
Lysis protein S of phage lambda functions in Saccharomyces cerevisiae. J Bacteriol (1990) 1.15
Schedule-induced drinking as a function of percentage reinforcement. J Exp Anal Behav (1975) 1.14
Seasonal pseudohyperkalaemia. J Clin Pathol (2003) 1.14
Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer (1983) 1.14
Transcription in bacteria at different DNA concentrations. J Bacteriol (1982) 1.14
Normative data stratified by age and education for the Neuropsychological Screening Battery for Hispanics (NeSBHIS): Initial report. J Int Neuropsychol Soc (1996) 1.13
Galactosaemia: a new severe variant due to uridine diphosphate galactose-4-epimerase deficiency. Arch Dis Child (1981) 1.13
The lysis protein E of phi X174 is a specific inhibitor of the MraY-catalyzed step in peptidoglycan synthesis. J Biol Chem (2000) 1.13
Conservation of a dual-start motif in P22 lysis gene regulation. J Bacteriol (1990) 1.11
Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas. Eur J Surg Oncol (2009) 1.10
Genomic and functional analyses of Rhodococcus equi phages ReqiPepy6, ReqiPoco6, ReqiPine5, and ReqiDocB7. Appl Environ Microbiol (2010) 1.09
Deletion analysis resolves cell-binding and lytic domains of the Pasteurella leukotoxin. Mol Microbiol (1990) 1.09
Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood (1993) 1.08
Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol (2006) 1.07
A system for gene cloning and manipulation in the yeast Candida glabrata. Gene (1994) 1.05
Characterization of plasmids with antimicrobial resistant genes in Pasteurella haemolytica A1. DNA Seq (1992) 1.05
L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist. Can J Physiol Pharmacol (1986) 1.04
VAD chemotherapy as remission induction for multiple myeloma. Br J Cancer (1995) 1.04
Methcathione ("cat"): an enantiomeric potency comparison. Pharmacol Biochem Behav (1995) 1.03
Secretion of the Pasteurella leukotoxin by Escherichia coli. FEMS Microbiol Lett (1989) 1.02
Macromolecular composition of bacteria. J Theor Biol (1982) 1.01
The Aymara of Western Bolivia. IV. Gene frequencies for eight blood groups and 19 protein and erythrocyte enzyme systems. Am J Hum Genet (1978) 0.99
Separable domains define target cell specificities of an RTX hemolysin from Actinobacillus pleuropneumoniae. J Bacteriol (1992) 0.99
Effect of zinc supplementation on plasma high-density lipoprotein cholesterol and zinc. Am J Clin Nutr (1982) 0.98